[Trends in drug-hormone contraception].
D000463:Algestone Acetophenide / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D004357:Drug Synergism; D004967:Estrogens / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000009:adverse effects; D011372:Progestins / Q000009:adverse effects*; D019966:Substance-Related Disorders; D014592:Uterine Hemorrhage / Q000139:chemically induced
D003276:Contraceptives, Oral; D003692:Delayed-Action Preparations; D004967:Estrogens; D011372:Progestins; D008525:Medroxyprogesterone; D000463:Algestone Acetophenide
Entwicklungstendenzen in der medikamentöshormonelen Kontrazeption.